Literature DB >> 26530746

Combined Ventilation and Perfusion Imaging Correlates With the Dosimetric Parameters of Radiation Pneumonitis in Radiation Therapy Planning for Lung Cancer.

Tomoki Kimura1, Yoshiko Doi2, Takeo Nakashima3, Nobuki Imano2, Hideo Kawabata2, Ikuno Nishibuchi2, Tomoyuki Okabe2, Masahiro Kenjo2, Shuichi Ozawa2, Yuji Murakami2, Yasushi Nagata2.   

Abstract

PURPOSE: The purpose of this study was to prospectively investigate clinical correlations between dosimetric parameters associated with radiation pneumonitis (RP) and functional lung imaging. METHODS AND MATERIALS: Functional lung imaging was performed using four-dimensional computed tomography (4D-CT) for ventilation imaging, single-photon emission computed tomography (SPECT) for perfusion imaging, or both (V/Q-matched region). Using 4D-CT, ventilation imaging was derived from a low attenuation area according to CT numbers below different thresholds (vent-860 and -910). Perfusion imaging at the 10th, 30th, 50th, and 70th percentile perfusion levels (F10-F70) were defined as the top 10%, 30%, 50%, and 70% hyperperfused normal lung, respectively. All imaging data were incorporated into a 3D planning system to evaluate correlations between RP dosimetric parameters (where fV20 is the percentage of functional lung volume irradiated with >20 Gy, or fMLD, the mean dose administered to functional lung) and the percentage of functional lung volume. Radiation pneumonitis was evaluated using Common Terminology Criteria for Adverse Events version 4.0. Statistical significance was defined as a P value of <.05.
RESULTS: Sixty patients who underwent curative radiation therapy were enrolled (48 patients for non-small cell lung cancer, and 12 patients for small cell lung cancer). Grades 1, 2, and ≥3 RP were observed in 16, 44, and 6 patients, respectively. Significant correlations were observed between the percentage of functional lung volume and fV20 (r=0.4475 in vent-860 and 0.3508 in F30) or fMLD (r=0.4701 in vent-860 and 0.3128 in F30) in patients with grade ≥2 RP. F30∩vent-860 results exhibited stronger correlations with fV20 and fMLD in patients with grade ≥2 (r=0.5509 in fV20 and 0.5320 in fMLD) and grade ≥3 RP (r=0.8770 in fV20 and 0.8518 in fMLD).
CONCLUSIONS: RP dosimetric parameters correlated significantly with functional lung imaging.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26530746     DOI: 10.1016/j.ijrobp.2015.08.024

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  11 in total

1.  Regional Lung Function Profiles of Stage I and III Lung Cancer Patients: An Evaluation for Functional Avoidance Radiation Therapy.

Authors:  Yevgeniy Vinogradskiy; Leah Schubert; Quentin Diot; Timothy Waxweiller; Phillip Koo; Richard Castillo; Edward Castillo; Thomas Guerrero; Chad Rusthoven; Laurie Gaspar; Brian Kavanagh; Moyed Miften
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-07-15       Impact factor: 7.038

2.  Predicting radiation pneumonitis with fuzzy clustering neural network using 4DCT ventilation image based dosimetric parameters.

Authors:  Peng Huang; Hui Yan; Zhihui Hu; Zhiqiang Liu; Yuan Tian; Jianrong Dai
Journal:  Quant Imaging Med Surg       Date:  2021-12

3.  Investigating the Incidence of Pulmonary Abnormalities as Identified by Parametric Response Mapping in Patients With Lung Cancer Before Radiation Treatment.

Authors:  Daniel R Owen; Yilun Sun; Jim C Irrer; Matthew J Schipper; Caitlin A Schonewolf; Stefanie Galbán; Shruti Jolly; Randall K Ten Haken; C J Galbán; M M Matuszak
Journal:  Adv Radiat Oncol       Date:  2022-04-25

4.  Interim Analysis of a Two-Institution, Prospective Clinical Trial of 4DCT-Ventilation-based Functional Avoidance Radiation Therapy.

Authors:  Yevgeniy Vinogradskiy; Chad G Rusthoven; Leah Schubert; Bernard Jones; Austin Faught; Richard Castillo; Edward Castillo; Laurie E Gaspar; Jennifer Kwak; Timothy Waxweiler; Michele Dougherty; Dexiang Gao; Craig Stevens; Moyed Miften; Brian Kavanagh; Thomas Guerrero; Inga Grills
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-10-18       Impact factor: 7.038

5.  Modeling Patient-Specific Dose-Function Response for Enhanced Characterization of Personalized Functional Damage.

Authors:  Daniel Rocky Owen; Phillip S Boonstra; Benjamin L Viglianti; James M Balter; Matthew J Schipper; William C Jackson; Issam El Naqa; Shruti Jolly; Randall K Ten Haken; Feng-Ming Spring Kong; Martha M Matuszak
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-06-01       Impact factor: 7.038

6.  Functional image guided radiation therapy planning in volumetric modulated arc therapy for patients with malignant pleural mesothelioma.

Authors:  Yoshiko Doi; Tomoki Kimura; Takeo Nakashima; Yuki Takeuchi; Ippei Takahashi; Ikuno Nishibuchi; Yuji Murakami; Yasushi Nagata
Journal:  Adv Radiat Oncol       Date:  2017-02-02

7.  To Find a Better Dosimetric Parameter in the Predicting of Radiation-Induced Lung Toxicity Individually: Ventilation, Perfusion or CT based.

Authors:  Lin-Lin Xiao; Guoren Yang; Jinhu Chen; Xiaohui Wang; Qingwei Wu; Zongwei Huo; Qingxi Yu; Jinming Yu; Shuanghu Yuan
Journal:  Sci Rep       Date:  2017-03-15       Impact factor: 4.379

8.  Variations Between Dose-Ventilation and Dose-Perfusion Metrics in Radiation Therapy Planning for Lung Cancer.

Authors:  Yujiro Nakajima; Noriyuki Kadoya; Tomoki Kimura; Kazunari Hioki; Keiichi Jingu; Tokihiro Yamamoto
Journal:  Adv Radiat Oncol       Date:  2020-03-20

9.  Investigation of a Novel Deep Learning-Based Computed Tomography Perfusion Mapping Framework for Functional Lung Avoidance Radiotherapy.

Authors:  Ge Ren; Sai-Kit Lam; Jiang Zhang; Haonan Xiao; Andy Lai-Yin Cheung; Wai-Yin Ho; Jing Qin; Jing Cai
Journal:  Front Oncol       Date:  2021-03-24       Impact factor: 5.738

10.  Evaluation of the ΔV 4D CT ventilation calculation method using in vivo xenon CT ventilation data and comparison to other methods.

Authors:  Geoffrey G Zhang; Kujtim Latifi; Kaifang Du; Joseph M Reinhardt; Gary E Christensen; Kai Ding; Vladimir Feygelman; Eduardo G Moros
Journal:  J Appl Clin Med Phys       Date:  2016-03-08       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.